Selected Publications

Automated Contouring and Planning in Radiation Therapy: What Is 'Clinically Acceptable'? Baroudi H, Brock KK, Cao W, Chen X, Chung C, Court LE, El Basha MD, Farhat M, Gay S, Gronberg MP, Gupta AC, Hernandez S, Huang K, Jaffray DA, Lim R, Marquez B, Nealon K, Netherton TJ, Nguyen CM, Reber B, Rhee DJ, Salazar RM, Shanker MD, Sjogreen C, Woodland M, Yang J, Yu C, Zhao Y.  Diagnostics (Basel) 13(4), 2/2023. e-Pub 2/2023. PMCID: PMC9955359.

On the importance of interpretable machine learning predictions to inform clinical decision making in oncology. Lu SC, Swisher CL, Chung C, Jaffray D, Sidey-Gibbons C. Front Oncol 13:1129380, 2023. e-Pub 2/2023. PMCID: PMC10013157.

Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID‐19. Muhammad Aminu, Divya Yadav, Lingzhi Hong , Elliana Young , Paul Edelkamp, Jr., Maliazurina Saad, Morteza Salehjahromi, Pingjun Chen, Sheeba J. Sujit, Melissa M. Chen, Bradley Sabloff, Gregory Gladish, Patricia M. de Groot, Myrna C. B. Godoy, Tina Cascone, Natalie I. Vokes, Jianjun Zhang, Kristy K. Brock, Naval Daver, Scott E. Woodman, Hussein A. Tawbi, Ajay Sheshadri, J. Jack Lee, David Jaffray, D3CODE Team, Carol C. Wu, Caroline Chung, and Jia Wu. Cancers 15(275), 12/2022. 

Changes In Outcomes And Factors Associated With Survival In Melanoma Patients With Brain Metastases. Hasanov M, Milton DR, Bea Davies A, Sirmans E, Saberian C, Posada EL, Opusunju S, Gershenwald JE, Torres-Cabala CA, Burton EM, Colen R, Huse JT, Glitza Oliva IC, Chung C, McAleer MF, McGovern SL, Yeboa DN, Kim BYS, Prabhu SS, McCutcheon IE, Weinberg J, Lang FF, Tawbi HA, Li J, Haydu LE, Davies MA, Ferguson SD. Neuro Oncol. e-Pub 12/2022. PMID: 36510640.

A Prospective Study of Conventionally Fractionated Dose Constraints for Re-Irradiation of Primary Brain Tumors in Adults. McGovern SL, Luo D, Johnson J, Nguyen K, Li J, McAleer MF, Yeboa D, Grosshans DR, Ghia AJ, Chung C, Bishop AJ, Song J, Thall PF, Brown PD, Mahajan A. Pract Radiat Oncol. e-Pub 12/2022. PMID: 36596356.

PocketNet: A Smaller Neural Network For Medical Image Analysis. Adrian Celaya, Jonas A. Actor, Rajarajesawari Muthusivarajan, Evan Gates, Caroline Chung, Dawid Schellingerhout, Beatrice Riviere, and David Fuentes. IEEE Transactions on Medical Imaging, 11/2022. 

An Automated Treatment Planning Framework for Spinal Radiation Therapy and Vertebral-Level Second Check. Netherton TJ, Nguyen C, Cardenas CE, Chung C, Klopp AH, Colbert LE, Rhee DJ, Peterson CB, Howell R, Balter P, Court LE. Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):516-528. doi: 10.1016/j.ijrobp.2022.06.083. Epub 2022 Jul 3. PMID: 35787928.

Customizable landmark-based field aperture design for automated whole-brain radiotherapy treatment planning. Xiao Y, Cardenas C, Rhee DJ, Netherton T, Zhang L, Nguyen C, Douglas R, Mumme 
R, Skett S, Patel T, Trauernicht C, Chung C, Simonds H, Aggarwal A, Court L. J Appl Clin Med Phys. 2022 Nov 22:e13839. doi: 10.1002/acm2.13839. Epub ahead of print. PMID: 36412092. 

Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease.Goldman J, Hagiwara A, Yao J, Raymond C, Ong C, Bakhti R, Kwon E, Farhat M, Torres C, Erickson LG, Curl BJ, Lee M, Pope WB, Salamon N, Nghiemphu PL, Ji M, Eldred BS, Liau LM, Lai A, Cloughesy TF, Chung C, Ellingson BM.  Front Oncol 12:849993, 2022. e-Pub 3/2022. PMCID: PMC8964348. 

Predictive Radiation Oncology - A New NCI-DOE Scientific Space and Community. Buchsbaum JC, Jaffray DA, Ba D, Borkon LL, Chalk C, Chung C, Coleman MA, Coleman CN, Diehn M, Droegemeier KK, Enderling H, Espey MG, Greenspan EJ, Hartshorn CM, Hoang T, Hsiao HT, Keppel C, Moore NW, Prior F, Stahlberg EA, Tourassi G, Willcox KE. Radiat Res 197(4):434-445, 4/2022. e-Pub 1/2022. PMCID: PMC9058979. 

Protocol for mathematical prediction of patient response and survival to immune checkpoint inhibitor immunotherapy.   Butner JD, Farhat M, Cristini V, Chung C, Wang Z. STAR Protoc 3(4):101886, 12/2022. e-Pub 11/2022. PMCID: PMC9719106. 

Brain Radiation Necrosis Outside the Target Volume After Proton Radiation Therapy: Analyses of Multiparametric Imaging and Proton Biologic Effectiveness. Bronk JK, Amer A, Khose S, Flint D, Adair A, Yepes P, Grosshans D, Johnson J, Chung C. Adv Radiat Oncol. 2022 Aug 6;7(6):101044. doi: 10.1016/j.adro.2022.101044. PMID: 36420203; PMCID: PMC9677210.

NIMG-79. Spatially Mapped Predictions of Evolving Tumor Response of High-Grade Glioma via Image-Driven Mathematical Modeling. Farhat, M & Hormuth, D & Langshaw, H & Bronk, J & Curl, B & Yadav, D & Upadhyay, R & Elliott, A & Goldman, J & Erickson, L & Talpur, W & Lee, M & Yankeelov, T & Chung, C. Neuro-Oncology, 11/2022. 

Opportunities for improving brain cancer treatment outcomes through imaging-based mathematical modeling of the delivery of radiotherapy and immunotherapy.    Hormuth DA, Farhat M, Christenson C, Curl B, Chad Quarles C, Chung C, Yankeelov TE.  Adv Drug Deliv Rev 187:114367, 8/2022. e-Pub 5/2022. PMID: 35654212. 

Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors. Ellingson BM, Gerstner ER, Lassman AB, Chung C, Colman H, Cole PE, Leung D, Allen JE, Ahluwalia MS, Boxerman J, Brown M, Goldin J, Nduom E, Hassan I, Gilbert MR, Mellinghoff IK, Weller M, Chang S, Arons D, Meehan C, Selig W, Tanner K, Alfred Yung WK, van den Bent M, Wen PY, Cloughesy TF. Neuro Oncol. 2022 Aug 1;24(8):1219-1229. doi: 10.1093/neuonc/noac086. PMID: 35380705; PMCID: PMC9340639.

Lessons learned from proton vs photon radiation therapy for glioblastoma signal-finding trial. Chung C, Brown PD, Wefel JS. Neuro Oncol. e-Pub 4/2022. PMID: 35460425. 

Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology. Wu C, Lorenzo G, Hormuth DA, Lima EABF, Slavkova KP, DiCarlo JC, Virostko J, Phillips CM, Patt D, Chung C, Yankeelov TE. Biophys Rev (Melville) 3(2):021304, 6/2022. e-Pub 5/2022. PMCID: PMC9119003. 

NEIM-06 Combining Clinical Variables and Radiomic Features to Help Distinguish Radiation Necrosis from Tumor in Patients with Melanoma Brain Metastases Treated with Radiosurgery. Tran B, Buszek S, Mitchell D, Long J, Elliott A, Langshaw H, Erickson L, Farhat M, Bronk J, Ferguson S, Chung C. Neuro-Oncology Advances, 8/2022. 

NEIM-05 Feasibility of Navigated Transcranial Magnetic Stimulation (nTMS) Based Diffusion Tensor Imaging (DTI) Tractography of Motor Pathways in Patients Undergoing Stereotactic Radiosurgery: A Cross-Sectional Dosimetric and Patient Outcomes Analysis. Bronk J, Muir M, Michener H, Calbat C, Mackin D, Mitchell D, Train B, Farhat M, Elliott A, Prabhu S, Prinsloo S, Chung C. Neuro-Oncology Advances, 8/2022.

Managing the effect of magnetic resonance imaging pulse sequence on radiomic feature reproducibility in the study of brain metastases. Mitchell, D & Buszek, S & Tran, B & Farhat, M & Goldman, J & Erickson, L & Curl, B & Suki, D & Ferguson, S & Liu, HL & Kundu, S & Chung, C. F1000 Research, 8/2022.

Neurocognitive Performance in Adults Treated With Radiation for a Primary Brain Tumor. Tsang DS, Khandwala MM, Liu ZA, Richard N, Shen G, Sekely A, Bernstein LJ, Simpson R, Mason W, Chung C, de Moraes FY, Murray L, Shultz D, Laperriere N, Millar BA, Edelstein K. Adv Radiat Oncol. 2022 Jul 16;7(6):101028. doi: 10.1016/j.adro.2022.101028. PMID: 36420185; PMCID: PMC9677214. 

Cancer Needs a Robust "Metadata Supply Chain" to Realize the Promise of Artificial Intelligence. Chung C, Jaffray DA. Cancer Res 81(23):5810-5812, 12/2021. PMID: 34853038.

Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study. Tawbi HA, Forsyth PA, Hodi FS, Algazi AP, Hamid O, Lao CD, Moschos SJ, Atkins MB, Lewis K, Postow MA, Thomas RP, Glaspy J, Jang S, Khushalani NI, Pavlick AC, Ernstoff MS, Reardon DA, Kudchadkar R, Tarhini A, Chung C, Ritchings C, Durani P, Askelson M, Puzanov I, Margolin KA. Lancet Oncol 22(12):1692-1704, 12/2021. e-Pub 11/2021. PMID: 34774225.

Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling. Butner JD, Martin GV, Wang Z, Corradetti B, Ferrari M, Esnaola N, Chung C, Hong DS, Welsh JW, Hasegawa N, Mittendorf EA, Curley SA, Chen SH, Pan PY, Libutti SK, Ganesan S, Sidman RL, Pasqualini R, Arap W, Koay EJ, Cristini V. Elife 10, 11/2021. e-Pub 11/2021. PMCID: PMC8629426. 

Math, magnets, and medicine: enabling personalized oncology. Hormuth DA, Jarrett AM, Lorenzo G, Lima EABF, Wu C, Chung C, Patt D, Yankeelov TE. Expert Rev Precis Med Drug Dev 6(2):79-81, 2021. e-Pub 1/2021. PMCID: PMC8133535.

The Role of the Immune Response in Brain Metastases: Novel Imaging Biomarkers for Immunotherapy.    Zakaria R, Radon M, Mills S, Mitchell D, Palmieri C, Chung C, Jenkinson MD.  Front Oncol 11:711405, 2021. e-Pub 10/2021. PMCID: PMC8577813. 

1039MO CheckMate 204: 3-year outcomes of treatment with combination nivolumab (NIVO) plus ipilimumab (IPI) for patients (pts) with active melanoma brain metastases (MBM). Tawbi, H & Forsyth, P.A. & Hodi, F.S. & Algazi, A. & Hamid, O. & Lao, C.D. & Moschos, S & Atkins, M.B. & Lewis, K. & Postow, M.A. & Thomas, R.P. & Khushalani, N.I. & Pavlick, A & Ernstoff, M & Reardon, D.A. & Chung, C & Lee, C-W & Bas, T & Askelson, M & Margolin, K. Annals of Oncology 32:S871-S872, 9/2021.

 A Prospective Phase II Randomized Trial of Proton Radiotherapy vs. Intensity Modulated Radiotherapy for Patients with Newly Diagnosed Glioblastoma.Brown PD, Chung C, Liu DD, McAvoy S, Grosshans D, Al Feghali K, Mahajan A, Li J, McGovern SL, McAleer MF, Ghia AJ, Sulman EP, Penas-Prado M, de Groot JF, Heimberger AB, Wang J, Armstrong TS, Gilbert MR, Guha-Thakurta N, Wefel JS.  Neuro Oncol 23(8):1337-1347, 8/2021. e-Pub 2/2021. PMCID: PMC8328012. 

The Effect of Slice Thickness on Contours of Brain Metastases for Stereotactic Radiosurgery.    Thrower SL, Al Feghali KA, Luo D, Paddick I, Hou P, Briere T, Li J, McAleer MF, McGovern SL, Woodhouse KD, Yeboa DN, Brock KK, Chung C.  Adv Radiat Oncol 6(4):100708, Jul-Aug, 7/2021. e-Pub 4/2021. PMCID: PMC8175282. 

Magnetic resonance biomarkers in radiation oncology: The report of AAPM Task Group 294. McGee KP, Hwang KP, Sullivan DC, Kurhanewicz J, Hu Y, Wang J, Li W, Debbins J, Paulson E, Olsen JR, Hua CH, Warner L, Ma D, Moros E, Tyagi N, Chung C. Med Phys 48(7):e697-e732, 7/2021. e-Pub 5/2021. PMCID: PMC8361924.

Predictors of overall survival (OS) in patients (pts) with melanoma brain metastasis (MBM) in the modern era. Hasanov, M & Milton, D & Davies, A & Sirmans, E & Saberian, C & Posada, E & Gershenwald, J & Torres-Cabala, C & Huse, J & Hassan, A & Glitza, I & Li, J & Chung, C & Yeboa, D & Opusunju, S & Kim, B & Lang, F & Haydu, L & Davies, M & Ferguson, S. Journal of Clinical Oncology 39:9540-9540, 5/2021. 

Real-world evaluation of the impact of radiotherapy and chemotherapy in elderly patients with glioblastoma based on age and performance status.    Al Feghali KA, Buszek SM, Elhalawani H, Chevli N, Allen PK, Chung C.  Neurooncol Pract 8(2):199-208, 4/2021. e-Pub 10/2020. PMCID: PMC8049423. 

Image-based personalization of computational models for predicting response of high-grade glioma to chemoradiation. Hormuth DA, Al Feghali KA, Elliott AM, Yankeelov TE, Chung C. Sci Rep 11(1):8520, 4/2021. e-Pub 4/2021. PMCID: PMC8055874. 

A mathematical model for the quantification of a patient's sensitivity to checkpoint inhibitors and long-term tumour burden. Butner JD, Wang Z, Elganainy D, Al Feghali KA, Plodinec M, Calin GA, Dogra P, Nizzero S, Ruiz-Ramírez J, Martin GV, Tawbi HA, Chung C, Koay EJ, Welsh JW, Hong DS, Cristini V.  Nat Biomed Eng 5(4):297-308, 4/2021. e-Pub 1/2021. PMID: 33398132. 

Simultaneous Truth and Performance Level Estimation Method for Evaluation of Target Contouring in Radiosurgery. SandstrÖm H, Toma-Dasu I, Chung C, GÅrding J, Jokura H, Dasu A. Anticancer Res 41(1):279-288, 1/2021. PMID: 33419822. 

Multi-Institutional Competing Risks Analysis of Distant Brain Failure and Salvage Patterns after Upfront Radiosurgery without Whole Brain Radiotherapy for Brain Metastasis. McTyre E, Ayala-Peacock D, Contessa J, Corso C, Chiang V, Chung C, Fiveash J, Ahluwalia M, Kotecha R, Chao S, Attia A, Henson A, Hepel J, Braunstein S, Chan M. Ann Oncol 29(2):497-503, 2/2018. e-Pub 11/2017. PMID: 29161348.

Stereotactic Body Radiation Therapy: Focusing on the Short Game. Cao C, Huang J, Rimner A, Wang D, Chung C, Jones DR. J Clin Oncol 36(23):2455-2456, 8/2018. e-Pub 6/2018. PMID: 29863976. 

The Use of 68Ga-DOTATATE PET/CT in the Non-Invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report. Al Feghali KA, Yeboa DN, Chasen B, Gule MK, Johnson JM, Chung C. Front Oncol 8:454, 2018. e-Pub 10/2018. PMCID: PMC6198069.

Review of Intracranial Meningiomas: An Update on Management from Diagnosis to Treatment. Al Feghali KA, Hilal L, Chung C. Internal Medicine Review, 4/2018.

Proton Therapy Reduces the Likelihood of High-Grade Radiation-Induced Lymphopenia in Glioblastoma Patients: Phase II Randomized Study of Protons vs. Photons. Mohan R, Liu AY, Brown PD, Mahajan A, Dinh J, Chung C, McAvoy S, McAleer MF, Lin SH, Li J, Ghia AJ, Zhu C, Sulman EP, de Groot JF, Heimberger AB, McGovern SL, Grassberger C, Shih H, Ellsworth S, Grosshans DR.  Neuro Oncol 23(2):284-294, 2/2021. e-Pub 8/2020. PMCID: PMC7906048. 

Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment.Al Feghali KA, Randall JW, Liu DD, Wefel JS, Brown PD, Grosshans DR, McAvoy SA, Farhat MA, Li J, McGovern SL, McAleer MF, Ghia AJ, Paulino AC, Sulman EP, Penas-Prado M, Wang J, de Groot J, Heimberger AB, Armstrong TS, Gilbert MR, Mahajan A, Guha-Thakurta N, Chung C. Neurooncol Adv 3(1):vdab073, Jan-Dec, 1/2021. e-Pub 6/2021. PMCID: PMC8320688. 

Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases (BTIP-BM). Kaufmann TJ, Smits M, Boxerman J, Huang R, Barboriak DP, Weller M, Chung C, Tsien C, Brown PD, Shankar L, Galanis E, Gerstner E, van den Bent MJ, Burns TC, Parney IF, Dunn G, Brastianos PK, Lin NU, Wen PY, Ellingson BM. Neuro Oncol 22(6):757-772, 6/2020. PMID: 32048719. 

Exclusion of Patients with Brain Metastases from Cancer Clinical Trials. Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller CD, Sulman EP, Yeboa DN, Chung CC, McAleer MF, Li J, Yoshor D, de Groot JF, Mandel JJ, Ludmir EB. Neuro Oncol 22(4):577-579, 4/2020. e-Pub 1/2020. 

Detection of Glioblastoma Subclinical Recurrence Using Serial Diffusion Tensor Imaging. Jin Y, Randall JW, Elhalawani H, Feghali KAA, Elliott AM, Anderson BM, Lacerda L, Tran BL, Mohamed AS, Brock KK, Fuller CD, Chung C. Cancers (Basel) 12(3), 2/2020. e-Pub 2/2020. PMCID: PMC7139975. 

Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery. McTyre ER, Soike MH, Farris M, Ayala-Peacock DN, Hepel JT, Page BR, Shen C, Kleinberg L, Contessa JN, Corso C, Chiang V, Henson-Masters A, Cramer CK, Ruiz J, Pasche B, Watabe K, D'Agostino R, Su J, Laxton AW, Tatter SB, Fiveash JB, Ahluwalia M, Kotecha R, Chao ST, Braunstein SE, Attia A, Chung C, Chan MD.  Radiother Oncol 142:168-174, 1/2020. e-Pub 9/2019. PMID: 31526671.

Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database. Buszek, S.M., Al Feghali, K.A., Elhalawani, H. et al. Sci Rep 10, 4926 (2020). https://doi.org/10.1038/s41598-020-61701-z

Unified platform for multimodal voxel-based analysis to evaluate tumour perfusion and diffusion characteristics before and after radiation treatment evaluated in metastatic brain cancer.
Coolens C, Driscoll B, Foltz W, Svistoun I, Sinno N, Chung C. Br J Radiol. 2019 Apr;92(1096):20170461. doi: 10.1259/bjr.20170461. Epub 2019 Feb 26.

Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, et al. Nat Rev Clin Oncol 16(8):521-522, 8/2019. PMID: 31150024.

Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials.
Shukla-Dave A, Obuchowski NA, Chenevert TL, Jambawalikar S, Schwartz LH, Malyarenko D, Huang W, Noworolski SM, Young RJ, Shiroishi MS, Kim H, Coolens C, Laue H, Chung C, Rosen M, Boss M, Jackson EF. J Magn Reson Imaging. 2019 Jun;49(7):e101-e121. doi: 10.1002/jmri.26518. Epub 2018 Nov 19. Review.

Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose.
Moraes FY, Winter J, Atenafu EG, Dasgupta A, Raziee H, Coolens C, Millar BA, Laperriere N, Patel M, Bernstein M, Kongkham P, Zadeh G, Conrad T, Chung C, Berlin A, Shultz DB. Neuro Oncol. 2019 Feb 14;21(2):242-251. doi: 10.1093/neuonc/noy159.

Detectability of radiation-induced changes in magnetic resonance biomarkers following stereotactic radiosurgery: A pilot study.
Winter JD, Moraes FY, Chung C, Coolens C. PLoS One. 2018 Nov 26;13(11):e0207933. doi: 10.1371/journal.pone.0207933. eCollection 2018.

Phantom Validation of DCE-MRI Magnitude and Phase-Based Vascular Input Function Measurements.
Foltz W, Driscoll B, Laurence Lee S, Nayak K, Nallapareddy N, Fatemi A, Ménard C, Coolens C, Chung C. Tomography. 2019 Mar;5(1):77-89. doi: 10.18383/j.tom.2019.00001.

Radiofrequency transmit calibration: A multi-center evaluation of vendor-provided radiofrequency transmit mapping methods.
Bliesener Y, Zhong X, Guo Y, Boss M, Bosca R, Laue H, Chung C, Sung K, Nayak KS. Med Phys. 2019 Jun;46(6):2629-2637. doi: 10.1002/mp.13518. Epub 2019 Apr 15.

Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience.
Hughes RT, Masters AH, McTyre ER, Farris MK, Chung C, Page BR, Kleinberg LR, Hepel J, Contessa JN, Chiang V, Ruiz J, Watabe K, Su J, Fiveash JB, Braunstein S, Chao S, Attia A, Ayala-Peacock DN, Chan MD. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1091-1098. doi: 10.1016/j.ijrobp.2019.03.052. Epub 2019 Apr 6.

Safety and Feasibility of Magnetic Resonance Imaging Simulation for Radiation Treatment Planning in Pediatric Patients: A Single Institution Experience.
Buszek SM, Ikner S, Wiedemann L, Wang J, McAleer MF, Grosshans DR, Paulino AC, McGovern SL, Chung C. Adv Radiat Oncol. 2018 Dec 21;4(2):362-366. doi: 10.1016/j.adro.2018.12.002. eCollection 2019 Apr-Jun.

The joint effect of aging and HIV infection on microstructure of white matter bundles.
Kuhn T, Jin Y, Huang C, Kim Y, Nir TM, Gullett JM, Jones JD, Sayegh P, Chung C, Dang BH, Singer EJ, Shattuck DW, Jahanshad N, Bookheimer SY, Hinkin CH, Zhu H, Thompson PM, Thames AD. Hum Brain Mapp. 2019 Jul 4. doi: 10.1002/hbm.24708. [Epub ahead of print]

Informational needs of brain metastases patients and their caregivers.
Papadakos J, Agarwal A, Charow R, Quartey NK, D'souza A, Giuliani M, Millar BA, Massey C, Shultz D, Chung C. Neurooncol Pract. 2019 Jan;6(1):47-60. doi: 10.1093/nop/npy008. Epub 2018 Apr 20.

Toxicity of Radiosurgery for Brainstem Metastases.
Patel A, Dong T, Ansari S, Cohen-Gadol A, Watson GA, Moraes FY, Nakamura M, Murovic J, Chang SD, Hatiboglu MA, Chung C, Miller JC, Lautenschlaeger T. World Neurosurg. 2018 Nov;119:e757-e764. doi: 10.1016/j.wneu.2018.07.263. Epub 2018 Aug 8. Review.

Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.
Chung C, Bryant A, Brown PD. Cochrane Database Syst Rev. 2018 Jul 9;7:CD011492. doi: 10.1002/14651858.CD011492.pub2. Review.

Multi-institutional study of the variability in target delineation for six targets commonly treated with radiosurgery.
Sandström H, Jokura H, Chung C, Toma-Dasu I. Acta Oncol. 2018 Nov;57(11):1515-1520. doi: 10.1080/0284186X.2018.1473636. Epub 2018 May 22.

Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers.
Joint Head and Neck Radiotherapy-MRI Development Cooperative. Sci Data. 2018 Feb 13;5:180008. doi: 10.1038/sdata.2018.8. Erratum in: Sci Data. 2018 Mar 20;5:180041.

Radiation-induced White Matter Injury Following Radiation Therapy in Glioblastoma patients.
Elhalawani H, Li T, Radwan S, Al Feghali K, Ding Y, Mohamed AS, Fuller CD, Zhu H, Chung C. International Journal of Radiation Oncology - Biology - Physics (2018); 102(3): e216.

Investigating Semi-Quantitative in-vivo Spatial and Dosimetric Analytical Algorithms to Report GBM Patterns of Failures following chemoradiation in the IMRT era.
Elhalawani H, Lin T, Al Feghali K, Radwan S, Chevli N, Mohamed AS, Fuller CD, Chung C. International Journal of Radiation Oncology - Biology - Physics (2018); 102(3): E241